Ligand · 1EL
1EL · 9-hydroxy-5,11-dimethyl-4,6-dihydro-1H-pyrido[4,3-b]carbazol-1-one
1EL, 9-hydroxy-5,11-dimethyl-4,6-dihydro-1H-pyrido[4,3-b]carbazol-1-one (C17 H14 N2 O2, 278.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues…
- Component
- 1EL
- Formula
- C17 H14 N2 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
1EL in 2 structures; the first of them:
- 3OWJ · Human CK2 catalytic domain in complex with a pyridocarbazole derivative inhibitor · 1EL A332 · binds LEU45, GLY46, ARG47, VAL53, VAL66, ILE95, PHE113, GLU114 and 6 more
- 3OWJ · Human CK2 catalytic domain in complex with a pyridocarbazole derivative inhibitor · 1EL A332 · binds LEU45, GLY46, ARG47, VAL53, VAL66, ILE95, PHE113, GLU114 and 6 more
Residues it binds most
VAL 2, HIS 2, ILE 2, ARG 2, ASP 2, GLU 2, GLY 2, LEU 2, MET 2, PHE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.